Immuneering CorporationIMRXNASDAQ
Loading
Operating Expenses Over TimeStrong
Percentile Rank83
3Y CAGR+4.2%
5Y CAGR+26.5%
Year-over-Year Change
Expenses from normal business operations (SG&A, R&D, etc.)
3Y CAGR
+4.2%/yr
Annual compound
5Y CAGR
+26.5%/yr
Recent deceleration
Percentile
P83
Within normal range
vs 5Y Ago
3.2x
Strong expansion
Streak
1 yr
Consecutive declineStrong
| Period | Value | YoY Change |
|---|---|---|
| TTM | $58.68M | -8.4% |
| 2024 | $64.07M | +9.7% |
| 2023 | $58.41M | +12.5% |
| 2022 | $51.90M | +49.1% |
| 2021 | $34.81M | +92.2% |
| 2020 | $18.11M | +159.2% |
| 2019 | $6.99M | - |